CARB-X

CARB-X is a global non-profit partnership focused on accelerating the development of products that address the critical issue of drug-resistant bacteria. By funding innovative antibacterial research and development, CARB-X plays a vital role in combating the global threat posed by antimicrobial resistance. With a strong commitment to innovation and impact, CARB-X supports a diverse portfolio of projects aimed at creating new solutions for treating and preventing drug-resistant infections.

Based in Boston, Massachusetts, at 771e Commonwealth Ave, CARB-X is dedicated to fostering collaboration and driving progress in the fight against antibiotic resistance. Through strategic investments and partnerships, CARB-X empowers researchers and organizations to develop novel therapeutics, vaccines, and diagnostics that can save lives and improve public health outcomes worldwide. CARB-X’s efforts are instrumental in advancing the field of antibacterial research and ensuring a future where drug-resistant infections are effectively addressed.

CARB-X is poised for continued growth and impact in the years to come. The organization's dedication to innovation, collaboration, and public health makes it a key player in the global effort to combat antimicrobial resistance. We encourage the management team at CARB-X to create a customized and exclusive company showcase and product listing on our platform, further amplifying their reach and impact.